Basics Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $436.05M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.71% Avg Daily Range (30 D): $0.35 | 2.03% Avg Daily Range (90 D): $0.36 | 2.01% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 71 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $.96M Avg Inst. Trade (90 D): $.88M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.18M Avg Closing Trade (30 D): $.96M Avg Closing Trade (90 D): $.87M Avg Closing Volume: 194.51K     News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.26 $-.07 $-.1 Diluted EPS $-.07 Revenue $ 70.32M $ 22.46M $ 18.93M Gross Profit $ 36.12M $ 7.86M $ 11.92M Net Income / Loss $ -6.68M $ -1.93M $ -2.59M Operating Income / Loss $ -2.68M $ -1.36M $ -1.48M Cost of Revenue $ 34.2M $ 14.6M $ 7M Net Cash Flow $ 16.86M $ 22.19M $ M PE Ratio